Navigation Links
BioElectronics Corporation Announces Initiative for UK and German Markets
Date:7/12/2012

FREDERICK, Md., July 12, 2012 /PRNewswire/ -- BioElectronics Corporation ("BioElectronics") (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced the formation of ActiPatch Plc, an entity through which BioElectronics proposes to conduct all sales, marketing, advertising and distribution functions for BioElectronics' medical devices in the German (81.3 million people) and United Kingdom (60 million people) markets.  BioElectronics will manage the operations of ActiPatch Plc, which will focus on promoting Allay for menstrual pain and the ActiPatch products for musculoskeletal pain.

"The German and UK markets are ideal markets for sustained direct to consumer advertising campaigns for our home use pain devices," said Andrew Whelan, CEO and President, BioElectronics.  Menstrual pain affects nearly 50% of women capable of reproducing and a recent EU Commission study suggests that 14.2 million people in Germany and 9.6 million in the UK suffered pain in their lower or upper back in the previous week.  BioElectronics' products have broad market clearances in the EU and UK where shortwave therapy is well understood and widely used by medical professionals.

"We have engaged a London-based team to put together the new company and coordinate the proposed PLUS-quoted application process," Mr. Whelan said.  The Corporate Adviser, SVS Securities Plc, is leading the team which includes the accounting firm, Bennett Brooks & Co, Ltd. and the law firm of Irvine and Partners.

About SVS Securities Plc
SVS Securities Plc (www.svssecurities.com) focuses on advising and assisting small to mid-sized companies in growth markets who may seek to raise funds.

About BioElectronics Corporation
BioElectronics is a developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care method to reduce soft tissue pain and swelling. The Company also manufactures HealFast™ Therapy (http://www.healfasttherapy.com) which is sold by eMarkets Group.  For more information, please visit www.bielcorp.com.

For media inquiries, please contact:

Paul Knopick
940.262.3584
pknopick@eandecommunications.com
E&E Communications


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
2. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
3. BioElectronics ActiPatch Reduces Muscle Soreness in Runners
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
6. Luminex Corporation Announces Agreement to Acquire GenturaDx
7. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
8. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
9. Celladon Corporation Receives Notice of Allowance from European Patent Office
10. FMC Corporation Acquires Phytone, Ltd., a Leading European Natural Colors Business
11. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the latest ... Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... include new preclinical and clinical data on Bayer,s marketed portfolio ... pipeline projects. "We ... minds in cancer research at ESMO," said Carsten Brunn ...
(Date:8/29/2017)... , Aug. 29, 2017 In a ... security, and regulatory compliance for veterinary practices of all ... a new partnership that makes TITAN,s expertise in physical ... available to Cubex,s clients nationally. ... buying and handling controlled substances is at risk today," ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... ... a neurosurgeon, has received a big bump in sales after recently going ... currently available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, RevNutrition.com and Go4ItNutrition.com. ...
(Date:9/19/2017)... Glen Cove, New York (PRWEB) , ... September 19, 2017 , ... ... that its dentist, Dr. Andrew Sami, was recently named one of the best dentists ... the leading lifestyle magazine for dental professionals nationwide. Every fall, the magazine features the ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... update their mobile app offering. The new app provides a modern design with ... the overall shopping experience. , The fred’s Pharmacy mobile app includes hundreds of ...
(Date:9/18/2017)... ... September 19, 2017 , ... Food ... market , expected to grow at the fastest CAGR of 9.1% over the ... Food Protein Trends & Growth Opportunities in Asia’ – highlighting alternative proteins, sustainable ...
(Date:9/18/2017)... ... September 18, 2017 , ... Allegheny Health Network’s (AHN) string of standout ... fifth consecutive year, AHN earned more honors than any health care provider in the ... dinner Sept. 14 at the Omni William Penn Hotel in downtown Pittsburgh included:, ...
Breaking Medicine News(10 mins):